Simple jQuery Dropdowns
Please use this identifier to cite or link to this item:
Title: Aberrant cyclooxygenase isozyme expression in human intrahepatic cholangiocarcinoma
Authors: S. Chariyalertsak
V. Sirikulchayanonta
D. Mayer
A. Kopp-Schneider
G. Fürstenberger
F. Marks
K. Müller-Decker
National Cancer Institute Thailand
Mahidol University
German Cancer Research Center
Keywords: Medicine
Issue Date: 19-Jan-2001
Citation: Gut. Vol.48, No.1 (2001), 80-86
Abstract: Methods - Cellular localisation of the cyclooxygenase (COX) isozymes COX-1 and COX-2 was analysed in 24 cholangiocarcinomas, including 17 matched tissues originating from non-tumorous liver tissue adjacent to tumours and seven biopsies of normal human liver, by immunohistochemistry using isozyme selective antibodies. Results - In normal liver, constitutive expression of COX-2 protein was a characteristic feature of hepatocytes whereas no COX-2 immunosignal was detectable in normal bile duct epithelium, Kupffer, and endothelial cells. In cholangiocarcinoma cells, COX-2 protein was strongly expressed at high frequency. The intensity, percentage of positive cells, and pattern of COX-2 expression were found to be independent of the stage of tumour differentiation. In hepatocytes of matched nontumorous tissue, COX-2 expression was unaltered. In contrast, strong COX-1 expression was frequently localised to Kupffer cells, endothelial cells, and occasionally to hepatocytes, but not to bile duct epithelial cells. In approximately half of moderately and poorly differentiated but not well differentiated cholangiocarcinomas, weak to moderate COX-1 staining was found in tumour cells while COX-1 expression in Kupffer cells was much more pronounced. Conclusion - Aberrant COX-2 expression occurs during the early stage while COX-1 over expression seems to be related to later stages of cholangiocarcinogenesis.
ISSN: 00175749
Appears in Collections:Scopus 2001-2005

Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.